Author:
Savchenko R. R.,Vasilyev S. A.,Fishman V. S.,Sukhikh E. S.,Sukhikh L. G.,Murashkina A. A.,Lebedev I. N.
Reference42 articles.
1. Andreassen, C.N., Searching for genetic determinants of normal tissue radiosensitivity—are we on the right track? Radiother. Oncol., 2010, vol. 97, no. 1, pp. 1—8. https://doi.org/10.1016/j.radonc.2010.07.018
2. Guo, Z., Shu, Y., Zhou, H., et al., Radiogenomics helps to achieve personalized therapy by evaluating patient responses to radiation treatment, Carcinogenesis, 2015, vol. 36, no. 3, pp. 307—317. https://doi.org/10.1093/carcin/bgv007
3. Surrallés, J., Jackson, S.P., Jasin, M., et al., Molecular cross-talk among chromosome fragility syndromes, Genes Dev., 2004, vol. 18, no. 12, pp. 1359—1370. https://doi.org/10.1101/gad.1216304
4. Chrzanowska, K.H., Gregorek, H., Dembowska-Bagińska, B., et al., Nijmegen breakage syndrome (NBS), Orphanet J. Rare Dis., 2012, vol. 7, no. 1, p. 13. https://doi.org/10.1186/1750-1172-7-13
5. Vasil’ev, S.A., Characteristics of spontaneous and induced mutagenesis in somatic human cells with different epigenetic background, Doctoral (Biol.) Dissertation, Tomsk: Tomsk National Research Medical Center Russian Academy of Sciences, 2018, p. 332.